CVE-2026-32921Disclosure(openclaw / openclaw)

LOWCVSS 5.0 · MEDIUM

Signal is active with 2 mentions in latest observed window

Immediate actions

  • Patch openclaw openclaw systems immediately

Recommended action window: Monitor and triage in normal cycle

NVD description

OpenClaw before 2026.3.8 contains an approval bypass vulnerability in system.run where mutable script operands are not bound across approval and execution phases. Attackers can obtain approval for script execution, modify the approved script file before execution, and execute different content while maintaining the same approved command shape.

0.5/ 10 priority

Sources & remediation

Weakness type (CWE)
CWE-367

Priority

LOW

Exploitation

NONE

PoC

NONE

Patch

AVAILABLE

Momentum

NONE

Are you affected?

If you run products in this scope, you should treat this CVE as relevant to your environment.

  • openclaw

Threat summary

  • Patch or workaround signal is available
  • 2 mentions across 1 observed day

What's happening

  • Patch or workaround mentioned in 1 signal
  • Technical details provided in 2 signals
  • Disclosure: 1 classified signal
  • 2 total mentions across 1 day

Affected systems

Vendors
Products
openclaw

Deep dive

Activity timeline2 mentions / 1d
01122Mentions · 2026-03-31: 2Patch / Workaround · 2026-03-31: 1Technical Details · 2026-03-31: 203-31
Signal classification2 categories
Disclosure
150.0%
Patch
150.0%
Referenced assets2 URLs
By indicator
Full discourse2 posts
  • CVE@CVEnew
    Disclosure

    CVE-2026-32921 OpenClaw before 2026.3.8 contains an approval bypass vulnerability in http://system.run where mutable script operands are not bound across approval and execution phases. Att… https://www.cve.org/CVERecord?id=CVE-2026-32921

    Post summary

    The tweet announces CVE‑2026‑32921, an approval bypass flaw in OpenClaw’s system.run component that occurs because mutable script operands aren’t correctly bound between approval and execution. No PoC, exploit code, patch, or active exploitation detail is provided.

    00010141
    56.9K followersView on X
  • Agentic Yield@AgenticYield
    Patch

    OpenClaw CVE-2026-32921: approval bypass in http://system.run — script operands change between approval and execution phases. Affects versions before 2026.3.8. Patch before relying on approval gates as a security control. https://www.cve.org/CVERecord?id=CVE-2026-32921

    Post summary

    The notice highlights an approval‑bypass flaw in OpenClaw pre‑2026.3.8 and urges applying the available patch; no exploit or active use is reported.

    0000042
    12 followersView on X
CPE platform detail1 entries

1 of 1 entries

PartVendorProductVersionTarget SWTarget HW
Appopenclawopenclaw-node.js-

Explore more